COTAZYM · 35000 UNIT + 10000 UNIT + 40000 UNIT · CAPSULE (IMMEDIATE-RELEASE)
Médicament · Health Canada · Canada
-
DIN
00263818 -
Code de médicament DPD
1649 -
ATC
A09AA02 -
AIG
0302964032
Ce que publie la source
- Titulaire
- ORGANON CANADA INC.
- Forme
- CAPSULE (IMMEDIATE-RELEASE)
- Voies d’administration
- ORAL
- Statut administratif
- authorised
- Régime de délivrance
- PRESCRIPTION
- Prescription
- Sur ordonnance ou à délivrance restreinte
Noms permettant de trouver cette fiche
- COTAZYM · 35000 UNIT + 10000 UNIT + 40000 UNIT · CAPSULE (IMMEDIATE-RELEASE)
- COTAZYM
- PROTEASE
- LIPASE
- AMYLASE
Données complètes de la source
{
"din": "00263818",
"form": "CAPSULE (IMMEDIATE-RELEASE)",
"name": "COTAZYM · 35000 UNIT + 10000 UNIT + 40000 UNIT · CAPSULE (IMMEDIATE-RELEASE)",
"holder": "ORGANON CANADA INC.",
"routes": [
"ORAL"
],
"smpcUrl": null,
"atcCodes": [
"A09AA02"
],
"drugCode": "1649",
"marketed": true,
"packages": [
{
"upc": "",
"size": "",
"type": "",
"typeFr": "",
"drugCode": "1649",
"sizeUnit": "",
"sizeUnitFr": "",
"information": "100/1000"
}
],
"brandName": "COTAZYM",
"updatedAt": "22-MAR-2025",
"useDomain": "human",
"descriptor": null,
"leafletUrl": null,
"statusDate": "07-JAN-2022",
"biosimilars": [],
"brandNameFr": null,
"descriptorFr": null,
"productClass": "Human",
"publishedDin": "00263818",
"sourceStatus": "MARKETED",
"supplyRegime": "PRESCRIPTION",
"targetSpecies": [],
"categorization": null,
"ingredientGroup": "0302964032",
"publicationDate": "2026-11-02",
"sourcePartition": "marketed",
"dinNotApplicable": false,
"activeIngredients": [
{
"base": "N",
"code": "648",
"name": "PROTEASE",
"unit": "UNIT",
"nameFr": "Protéase",
"strength": "35000",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
},
{
"base": "N",
"code": "649",
"name": "LIPASE",
"unit": "UNIT",
"nameFr": "Lipase",
"strength": "10000",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
},
{
"base": "N",
"code": "253",
"name": "AMYLASE",
"unit": "UNIT",
"nameFr": "Amylase",
"strength": "40000",
"dosageUnit": null,
"dosageValue": null,
"strengthType": null,
"suppliedIndicator": "I"
}
],
"useDomainEvidence": {
"basis": "publisher-field",
"field": "class",
"value": "Human",
"version": 1,
"sourceId": "ca.health-canada.dpd"
},
"identifierWarnings": [],
"patientEligibility": "not-assessed",
"numberOfIngredients": "3",
"targetSpeciesStatus": "not-applicable",
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"pharmaceuticalStandards": [
"USP"
]
}
Lisez cette fiche depuis votre propre logiciel
La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=ca" \
--data-urlencode "sourceId=ca.health-canada.dpd" \
--data-urlencode "id=ca:health-canada:products:1649"